Marjan Hezareh

3.8k citations

30 papers · 2.9k indexed · 1 hit paper · h-index 18

Co-authors: Joseph K. Wong Celsa A. Spina Douglas D. Richman Caroline Ignacio Huldrych F. Günthard Diane V. Havlir Richard Christian Jensen Jan G. J. van de Winkel
Topics: HIV Research and Treatment (8 papers)Pneumonia and Respiratory Infections (7 papers)Bacterial Infections and Vaccines (7 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: Science The Lancet PLoS ONE
Partner nations: United States Belgium Switzerland

In The Last Decade

Marjan Hezareh

29 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

1997 1.7k citations Joseph K. Wong, Marjan Hezareh et al. profile →

Peers

Countries citing papers authored by Marjan Hezareh

Since Specialization

Citations

This map shows the geographic impact of Marjan Hezareh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjan Hezareh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjan Hezareh more than expected).

Fields of papers citing papers by Marjan Hezareh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjan Hezareh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjan Hezareh. The network helps show where Marjan Hezareh may publish in the future.

Co-authorship network of co-authors of Marjan Hezareh

This figure shows the co-authorship network connecting the top 25 collaborators of Marjan Hezareh. A scholar is included among the top collaborators of Marjan Hezareh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjan Hezareh. Marjan Hezareh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers 2023 ·Clinical Pharmacokinetics ·(unknown),Elizabeth Alexander,(unknown),(unknown),Stephen A. Harrison,(unknown),Marjan Hezareh,Andrew M. Lippa,(unknown),(unknown),(unknown),Jennifer E. Sager,Scott Segal,(unknown),Andrew Skingsley,Robert Williams,Esther Yoon,Daren Austin	2
2	Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children 2020 ·Vaccine ·Timo Vesikari,Aino Forstén,(unknown),Ping Li,Marie Van der Wielen,Marjan Hezareh,John L. Perez,Chris Webber	4
3	Risk behaviour and patient preferences for an improved non-melanoma skin cancer prevention modality for organ-transplanted patients: a European, multi-country, online patient community study 2019 ·European Journal of Dermatology ·N. Basset Seguin,Josep Malvehy,(unknown),Laurent Créancier,(unknown),(unknown),Marjan Hezareh,Anne-Marie Schmitt,(unknown)	2
4	Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study 2018 ·Vaccine ·Clare Cutland,Terry Nolan,Scott A. Halperin,Zafer Kurugöl,Khatija Ahmed,Kirsten P. Perrett,Peter Richmond,Helen Marshall,Mehmet Ceyhan,(unknown),Marjan Hezareh,Marie Van der Wielen	19
5	Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study 2018 ·Vaccine ·Nicola P. Klein,(unknown),Pavel Kosina,Nirmish Shah,(unknown),Jacqueline M. Miller,Marjan Hezareh,Marie Van der Wielen	9
6	Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART 2017 ·Virology ·Nadejda Beliakova‐Bethell,Marjan Hezareh,Joseph K. Wong,Matthew C. Strain,Mary K. Lewinski,Douglas D. Richman,Celsa A. Spina	18
7	Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial 2017 ·Vaccine ·Ting Fan Leung,(unknown),Fong Seng Lim,Franck Thollot,Helen May Lin Oh,Bee Wah Lee,Lars Rombo,Ngiap Chuan Tan,Roman Rouzier,(unknown),P.V. Suryakiran,Marjan Hezareh,Florence Thomas,Nicolas Folschweiller,Frank Struyf	22
8	Effectiveness of the 10-Valent Pneumococcal NontypeableHaemophilus influenzaeProtein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland 2016 ·Journal of the Pediatric Infectious Diseases Society ·Timo Vesikari,Aino Forstén,(unknown),Tarja Kaijalainen,Taneli Puumalainen,Anu Soininen,Magali Traskine,Patricia Lommel,Sonia Schoonbroodt,Marjan Hezareh,Marta Moreira,Dorota Borys,Lode Schuerman	70
9	Motivations for Intravaginal Product Use among a Cohort of Women in Los Angeles 2016 ·PLoS ONE ·Joelle Brown,Eugenie Poirot,Kristen L. Hess,Stephen Brown,(unknown),Marjan Hezareh	25
10	Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China 2016 ·Vaccine ·Rongcheng Li,(unknown),Yanping Li,Youping Liu,Zhao Hong,Xiaoling Chen,Sherine Kuriyakose,Olivier Van Der Meeren,Karin Hardt,Marjan Hezareh,Sumita Roy–Ghanta	9
11	Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial 2015 ·Human Vaccines & Immunotherapeutics ·Ting Fan Leung,(unknown),Fong Seng Lim,Franck Thollot,Helen May Lin Oh,Bee Wah Lee,Lars Rombo,Ngiap Chuan Tan,Roman Rouzier,Damien Friel,(unknown),(unknown),P.V. Suryakiran,Marjan Hezareh,Nicolas Folschweiller,Florence Thomas,Frank Struyf	41
12	A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia 2014 ·BMC Infectious Diseases ·Fong Seng Lim,(unknown),Kah Kee Tan,(unknown),Chia Yin Chong,(unknown),Yee Leong Teoh,(unknown),Marjan Hezareh,Kristien Swinnen,Dorota Borys	5
13	Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study 2013 ·Vaccine ·Lynette Denny,(unknown),(unknown),Florence Thomas,Marjan Hezareh,Kurt Dobbelaere,Christelle Durand,Caroline Hervé,Dominique Descamps	79
14	Intravaginal Practices and Risk of Bacterial Vaginosis and Candidiasis Infection Among a Cohort of Women in the United States 2013 ·Obstetrics and Gynecology ·Joelle Brown,Kristen L. Hess,Stephen J. Brown,Colleen Murphy,Ava Lena Waldman,Marjan Hezareh	58
15	Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial 2012 ·The Lancet ·Arto A. Palmu,Jukka Jokinen,Dorota Borys,Heta Nieminen,Esa Ruokokoski,Lotta Siira,Taneli Puumalainen,Patricia Lommel,Marjan Hezareh,Marta Moreira,Lode Schuerman,Terhi Kilpi	173
16	PACAP/VIP Receptor Subtypes, Signal Transducers, and Effectors in Pituitary Cellsa 2006 ·Annals of the New York Academy of Sciences ·Marjan Hezareh,Laurent Journot,(unknown),Werner Schlegel,Stephen R. Rawlings	5
17	Prostratin as a New Therapeutic Agent Targeting HIV Viral Reservoirs 2005 ·Drug News & Perspectives ·Marjan Hezareh	37
18	Potent and Selective Inhibition of HIV and SIV by Prostratin Interacting with Viral Entry 2003 ·Antiviral chemistry & chemotherapy ·Myriam Witvrouw,Christophe Pannecouque,Valery Fikkert,(unknown),Barbara Van Remoortel,Marjan Hezareh,Erik De Clercq,Stephen J. Brown	14
19	PACAP and VIP Stimulate Ca²⁺ Oscillations in Rat Gonadotrophs through the PACAP/VIP Type 1 Receptor (PVR1) Linked to a Pertussis Toxin‐Insensitive G‐Protein and the Activation of Phospholipase C‐β 1996 ·Journal of Neuroendocrinology ·Marjan Hezareh,Werner Schlegel,Stephen R. Rawlings	35
20	The Guanine-Nucleotide-Binding Protein Subunit Galphai2 is Involved in Calcium Activation of Phospholipase A2. Effects of the Dominant Negative Galphai2 Mutant, [G203T]Galphai2, on Activation of Phospholipase A2 in Chinese Hamster Ovary Cells 1995 ·European Journal of Biochemistry ·(unknown),John D. Reid,Isabelle Piuz,Marjan Hezareh,Werner Schlegel	26

About Marjan Hezareh

Marjan Hezareh is a scholar working on Virology, Microbiology and Infectious Diseases, having authored 30 papers that have together received 2.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), Pneumonia and Respiratory Infections (7 papers) and Bacterial Infections and Vaccines (7 papers). The work is most often cited by research in Virology (2.0k citations), Infectious Diseases (1.5k citations) and Immunology (791 citations). Marjan Hezareh has collaborated with scholars based in United States, Belgium and Switzerland. Frequent co-authors include Joseph K. Wong, Celsa A. Spina, Douglas D. Richman, Caroline Ignacio, Huldrych F. Günthard, Diane V. Havlir, Richard Christian Jensen, Jan G. J. van de Winkel, Paul W.H.I. Parren and Ann J. Hessell. Their work appears in journals such as Science, The Lancet and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact